top of page
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600589/

Working in close collaboration with Dr. Bryce Chackerian and Dr. David Peabody at the University of New Mexico, the Frietze Lab has developed a novel technology for investigating the specificity of antibodies in serum from humans.  This technology has been used by the Frietze Lab to investigate antibody responses to Dengue virus, Chlamydia trachomatis, and ovarian cancer.

  • LinkedIn

©2025 by Kathryn Frietze, PhD
Albuquerque, NM USA

bottom of page